Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net loss $ (9,396) $ (19,797)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation 2,024 1,792
Depreciation 1,642 1,690
Amortization of intangible assets 4,688 4,651
Deferred income taxes 492 (124)
Amortization of debt issuance costs and original issue discount 587 522
Change in fair value of warrant liabilities (2) (154)
Changes in current assets and liabilities:    
Accounts receivable 2,430 706
Inventories (9,626) 1,579
Prepaid expenses and other current assets (1,416) (740)
Accounts payable, accrued liabilities and income taxes (1,184) 14,084
Other, net 197 (142)
Net cash (used in) provided by operating activities (9,564) 4,067
Investing activities    
Capital expenditures (1,085) (1,556)
Proceeds from Sale of Equity Method Investments 200 0
Net cash used in investing activities (885) (1,556)
Financing activities    
Proceeds from revolving credit facility 11,000 0
Repayments of revolving credit facility (6,000) (4,000)
Repayments of long-term borrowings (938) (938)
Tax withholdings related to net share settlements of stock awards (463) (405)
Net cash provided by (used in) financing activities 3,599 (5,343)
Effect of exchange rate changes on cash and cash equivalents 87 788
Net change in cash and cash equivalents (6,763) (2,044)
Cash and cash equivalents, beginning of period 30,513 28,676
Cash and cash equivalents, end of period 23,750 26,632
Supplemental disclosure of cash flow information    
Interest paid 10,364 10,284
Taxes paid, net of refunds $ 1,212 $ 3,228